Company:AstraZeneca Pharmaceuticals (Ireland) DAC
Legal Category:Product subject to medical prescription which may be renewed (B)
*Additional information is available within the SPC or upon request to the company
Discontinued Strength Notice
Supply of Oxis 12mcg powder for inhalation to the Irish market will be discontinued by February 2024.